Related Experiment Videos

Aspects of care for the hepatitis C positive patient

A Wodak1

  • 1Alcohol and Drug Service, St Vincent's Hospital, Sydney, New South Wales.

Insights

Hepatitis C is Australia's most common chronic infection, primarily affecting those who inject drugs. While most infected individuals maintain a good quality of life, general practitioners play an increasing role in management.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C is Australia's most prevalent life-threatening chronic infection, with nearly 200,000 cases.
  • The majority of new infections are linked to injecting drug use, highlighting a critical public health challenge.

Purpose of the Study:

  • To address the lack of a national strategy for hepatitis C control in Australia.
  • To evaluate the current treatment landscape, characterized by high costs, moderate efficacy, and significant side effects.

Main Methods:

  • This study synthesizes existing data on hepatitis C prevalence, transmission, and treatment outcomes in Australia.
  • Analysis focuses on the epidemiology of new infections and the clinical profile of current treatments.

Main Results:

  • Over 90% of approximately 11,000 annual new hepatitis C infections in Australia are associated with injecting drug use.
  • Current hepatitis C treatments are expensive, less effective compared to treatments for other conditions, and have notable side effects.

Conclusions:

  • Most individuals with chronic hepatitis C can expect a normal life expectancy and good quality of life.
  • The involvement of general practitioners in the prevention and treatment of hepatitis C is becoming increasingly important.
Abstract

Related Concept Videos